Found 34 matching trials
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
PHASE2This is a prospective, single-arm trial. The main purpose of the study is t...
Location
Zhejiang Provincial People's Hospital
Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer
PHASE2Nimotuzumab, as one new agent used in advanced esophageal carcinoma, has be...
Nimotuzumab in Combined With Chemotherapy for Treatment of IVB Stage,Rrecurrent or Persistent Cervical Carcinoma
PHASE3This is an multicenter, randomized,double-blind, controlled clinical study....
Location
Cancer Institute and Hospital , Chinese Academy of Medical Sciences
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer
PHASE2Primary Objective:To evaluate the efficacy and safety of TIP (paclitaxel + ...
Location
Sun Yat-sen University Cancer Center
Adebrelimab Neoadjuvant Treatment for Resectable ESCC
NAThis is a prospective, phase II, exploratory clinical trial.
The study aim...
Location
Multiple Locations
Neoadjuvant Treatment of Nimotuzumab With Chemotherapy or Radiotherapy in Resectable Esophageal Squamous Cell Carcinoma
PHASE2Esophageal cancer is one of common malignant tumors in China and esophageal...
Location
Beijing Cancer Hospital & Peking University Cancer Hospital
Nimotuzumab Combined With Nab-paclitaxel/Gemcitabine in the Perioperative Treatment of High-risk Resectable/Borderline Resectable Pancreatic Cancer
PHASE2This is a prospective, multicenter, randomized, double-blind, placebo-contr...
Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma
PHASE2There have been reports suggesting that anti-epidermal growth factor antibo...
Location
The first affiliated hospital, Zhejiang University
Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
PHASE3In order to evaluate the efficacy and safety of nimotuzumab combined with p...
Location
National Sun Yat-sen University Cancer Center
Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma
PHASE2This study is a prospective, single-arm, multicenter study. The patients we...